In spring 2025, the Synapsy Center is launching the eponymous international prize, worth 50,000 CHF, which will be awarded for an outstanding mid- to advanced-career contribution at the intersection ...

– The review provides strong scientific rationale to support Alto’s drug development approach leveraging its Precision Psychiatry Platform – The article consolidates extensive clinical and ...

We often hear that the brain can be thought of as a type of computer. But how seriously should we take this metaphor? And might it tell us anything useful about psychiatric disorders? It’s not hard to ...

Alto Neuroscience, Inc. a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced multiple presentations at the ...

Strasbourg Translational Neuroscience and Psychiatry has the following research output in the current window (1 October 2024 - 30 September 2025) of the Nature Index. Click on Count to view a list of ...

Our strategic focus at the Division of Research within the Department of Psychiatry and Behavioral Neuroscience at Saint Louis University is to advance mental health initiatives with a particular ...

Canadian Science Publishing (CSP) is pleased to announce that the Journal of Psychiatry and Neuroscience (JPN) is now officially part of our journal portfolio, following the completed acquisition from ...

A new study is dampening some of the hype surrounding psychedelic therapy. It found that drugs like LSD and psilocybin are ...

Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment – The review provides strong scientific ...